Wild Katharina, Smits Maike, Killmer Saskia, Strohmeier Shirin, Neumann-Haefelin Christoph, Bengsch Bertram, Krammer Florian, Schwemmle Martin, Hofmann Maike, Thimme Robert, Zoldan Katharina, Boettler Tobias
Department of Medicine II, Medical Center - University of Freiburg, Freiburg, Germany.
Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Nat Commun. 2021 Nov 18;12(1):6720. doi: 10.1038/s41467-021-27064-3.
Effectiveness of seasonal influenza vaccination varies between individuals and might be affected by vaccination history among other factors. Here we show, by monitoring frequencies of CD4 T cells specific to the conserved hemagglutinin epitope HA and titres of IgG against the corresponding recombinant hemagglutinin protein, that antigen-specific CD4 T cell and antibody responses are closely linked to pre-existing immunity and vaccine history. Upon immunization, a strong early reaction is observed in all vaccine naïve participants and also in vaccine experienced individuals who have not received the respective seasonal vaccine in the previous year. This response is characterized by HA specific CD4 T cells with a follicular helper T cell phenotype and by ascending titers of hemagglutinin-specific antibodies from baseline to day 28 following vaccination. This trend was observed in only a proportion of those participants who received the seasonal vaccine the year preceding the study. Regardless of history, levels of pre-existing antibodies and CD127 expression on CD4 T cells at baseline were the strongest predictors of robust early response. Thus, both pre-existing immunity and vaccine history contribute to the response to seasonal influenza vaccines.
季节性流感疫苗的有效性因人而异,可能会受到疫苗接种史等其他因素的影响。在此,我们通过监测针对保守血凝素表位HA的CD4 T细胞频率以及针对相应重组血凝素蛋白的IgG滴度,发现抗原特异性CD4 T细胞和抗体反应与既往免疫力和疫苗接种史密切相关。免疫后,在所有未接种过疫苗的参与者以及前一年未接种相应季节性疫苗的有疫苗接种经验的个体中均观察到强烈的早期反应。这种反应的特征是具有滤泡辅助性T细胞表型的HA特异性CD4 T细胞以及接种疫苗后从基线到第28天血凝素特异性抗体滴度的上升。在研究前一年接种过季节性疫苗的参与者中,只有一部分呈现出这种趋势。无论接种史如何,基线时既往抗体水平和CD4 T细胞上的CD127表达是强烈早期反应的最强预测指标。因此,既往免疫力和疫苗接种史均有助于对季节性流感疫苗的反应。